Recent Update of Natural Compounds as HIF-1α Inhibitors in Colorectal Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Hypoxia-inducible factor (HIF)-1α regulates genes vital for oxygen homeostasis, promoting tumor development, angiogenesis, metastasis, metabolism, and immune evasion.
• Overexpression of HIF-1α correlates with poor prognosis in cancer patients, making it a significant therapeutic target.
• Natural compounds are a promising source for anticancer drugs, with demonstrated efficacy in modulating HIF-1α activity.

Purpose of the Study:

• To review natural products that target HIF-1α specifically in colorectal cancer.
• To identify novel therapeutic strategies for colorectal carcinoma management by focusing on HIF-1α inhibition.
• To summarize the role of HIF-1α in tumor progression and explore natural compounds as potential inhibitors.

Main Methods:

• Literature search of research publications on HIF-1α in cancer from 2010 to 2024.
• Focused analysis on studies related to natural compounds targeting HIF-1α in colorectal cancer.
• Synthesis of information on HIF-1α's role and natural product inhibitors.

Main Results:

• HIF-1α plays a critical role in various aspects of colorectal cancer progression.
• Several natural compounds have been identified as inhibitors of HIF-1α.
• The review consolidates information on these natural compounds for potential therapeutic applications.

Conclusions:

• Targeting HIF-1α with natural compounds presents a novel and promising therapeutic approach for colorectal cancer.
• Further research into these natural products could lead to the development of effective treatments for colorectal carcinoma.
• Natural product-based inhibition of HIF-1α offers a potential strategy to improve patient outcomes in colorectal cancer.